coteauBeta Get App

BTSG

BrightSpring Health Services
$62.36
-0.10% Oct 21 close
Health CareS&P 400 CompareTechnicals
-5%+31%+67%+103%+139%Oct 2025Oct 2026Apr 2026
BTSGSPY
1W
-1.6%
1M
+11.6%
3M
-10.6%
6M
+32.2%
YTD
+66.5%
1Y
+93.4%

Live chart

Loading live chart…

What they do

BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.

Healthcare · Health Information Services

For information only · Important disclosures

Grades vs sector

Momentum
87th percentile in sector
A-
12-1 return: +71.7%
Percentile within its GICS sector across the S&P 1500.
Growth
83rd percentile in sector
A-
Revenue growth (YoY): +23.0%
Percentile within its GICS sector across the S&P 1500.
Value
23rd percentile in sector
D
Forward E/P: 3.7% · EBITDA/EV: 4.4%
Percentile within its GICS sector across the S&P 1500.
Profitability
44th percentile in sector
C
Profit margin: +2.5% · Return on equity: +13.0%
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Our models

Not held by any of our 5 live models right now.

Quality Growth
Outside this model's universe or screens
Momentum Top 15
Outside this model's universe or screens
Momentum Blend
Not in the current book
New Highs Growth
Outside this model's universe or screens
Coteau Long Book
Not in the current book

News

More news
No recent headlines.

Key stats

52-week range$31.36 – $72.91
Valuation and fundamentals

Valuation & fundamentals

Bottom line
Leans undervalued
Model read-out from the numbers below, not advice. Score +1 (DCF counts double).
•DCF (base case)above the price by 7%
▲Piotroski F-score7/9
•Net debt / EBITDA2.7x

Discounted cash flow

Bear
$33
-47%
growth 11% · disc. 10.2% · term. 2.0%
Base
$67
+7%
growth 19% · disc. 9.2% · term. 2.5%
Bull
$117
+87%
growth 23% · disc. 8.2% · term. 3.0%

A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.

Reverse DCFfor context, not a signal
Not enough data to run a reverse DCF.
Edit assumptions · recalculates instantly
Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.00 (n/a) × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs Health Care

P/E (trailing)
sector median 29.9×
–
Forward P/E
sector median 17.6×
–
EV / EBITDA
sector median 15.8×
–
Price / sales
sector median 3.1×
–
Price / book
sector median 3.5×
–
FCF yield
sector median 4.1%
–

Quality & financial health

Gross margin
12.4%
Operating margin
3.1%
FCF margin
2.8%
Net margin
2.5%
Return on equity
17.9%
Return on invested capital
10.2%
Net debt / EBITDA
2.7×
Current ratio
1.6×
Interest cover
2.9×
Cash conversion (OCF/NI)
1.4×
Piotroski F-score 7/9 · last two fiscal years
✓ Positive net income✓ Positive operating cash flow✓ Return on assets improved✓ Cash flow above net income✓ Long-term debt / assets fell✓ Current ratio improved✗ No share dilution✗ Gross margin improved✓ Asset turnover improved

Analysts

No analyst targets available.

Annual history

FYRevenueNet incomeFree cash flow
2025$12.9B$190.7M$394.7M
2024$10.1B$-18.1M$-57.1M
2023$7.7B$-154.6M$137.3M
2022$7.7B$-53.9M$-74.8M

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +18.7%.

Earnings

Next report: 2026-10-30 · before open · EPS est 0.47
24-1125-0325-0525-0825-1026-0226-0526-070.000.45
EstimateActual (beat)Actual (miss)
ReportEPS estActualSurprise
2026-07-310.400.45+13.0%
2026-05-010.310.39+26.1%
2026-02-270.350.33-4.7%
2025-10-200.260.30+13.9%
2025-08-010.190.22+17.6%
2025-05-020.090.19+108.9%
2025-03-060.210.22+3.8%
2024-11-010.160.11-31.5%
Insider trades
Greenwell Scott A.
President, PharMerica · 2026-09-14
Sell
$874.4K
None
None · None
Sell
–

Stats refreshed 2026-10-21 17:59:09 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Free. Not investment advice. Unsubscribe anytime.

coteau

Independent research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

Beta 0.9 · Oct 21, 2026